Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,28 USD | -2,31% | -2,76% | +0,95% |
Omzet 2024 * | 1,38 mln. 1,29 mln. | Omzet 2025 * | 782K 733K | Marktkapitalisatie | 323 mln. 303 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -68 mln. -63,81 mln. | Nettowinst (verlies) 2025 * | -82 mln. -76,95 mln. | EV/omzet 2024 * | 234 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 413 x |
K/w-verhouding 2024 * |
-5,35
x | K/w-verhouding 2025 * |
-4,85
x | Werknemers | 88 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 77,47% |
Recentste transcriptie over Lyra Therapeutics, Inc.
1 dag | -2,31% | ||
1 week | -2,76% | ||
Lopende maand | -14,95% | ||
1 maand | -8,32% | ||
3 maanden | +3,93% | ||
6 maanden | +49,44% | ||
Lopend jaar | +0,95% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Maria Palasis
CEO | Chief Executive Officer | 59 | 01-01-15 |
Jason Cavalier
DFI | Director of Finance/CFO | 51 | 13-09-21 |
Richard Nieman
CTO | Chief Tech/Sci/R&D Officer | 61 | 11-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harlan Waksal
CHM | Chairman | 71 | 16-02-22 |
W. Smith
BRD | Director/Board Member | 68 | 19-11-19 |
James Tobin
BRD | Director/Board Member | 79 | 07-03-22 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 5,29 | -2,13% | 27 091 |
17-04-24 | 5,405 | +0,09% | 299 203 |
16-04-24 | 5,4 | +2,47% | 244 109 |
15-04-24 | 5,27 | -0,19% | 240 217 |
12-04-24 | 5,28 | -2,94% | 264 004 |
uitgestelde koers Nasdaq, 18 april 2024 om 16:17 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,95% | 323 mln. | |
-1,23% | 41,36 mld. | |
+45,26% | 41,3 mld. | |
+2,87% | 39,61 mld. | |
-15,14% | 25,62 mld. | |
+3,83% | 24,09 mld. | |
-23,73% | 18,38 mld. | |
+24,34% | 11,85 mld. | |
-2,65% | 11,82 mld. | |
+8,01% | 11,07 mld. |